This study has elegantly highlighted the possibility of exploiting promiscuous enzymes such as SPT to treat cancer by limiting the availability of the primary substrate, leading to the production of toxic lipid species, altering cellular membrane composition and ultimately impairing tumour growth. Here, AGXT is linked to neoplasm.